Walleye Capital’s TScan Therapeutics TCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-84,699
Closed -$422K 2630
2024
Q3
$422K Sell
84,699
-22,966
-21% -$114K ﹤0.01% 1410
2024
Q2
$630K Buy
107,665
+55,187
+105% +$323K ﹤0.01% 1352
2024
Q1
$417K Buy
52,478
+34,701
+195% +$276K ﹤0.01% 1475
2023
Q4
$104K Buy
+17,777
New +$104K ﹤0.01% 1615